지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 저널정보
- 대한정신약물학회 Clinical Psychopharmacology and Neuroscience Clinical Psychopharmacology and Neuroscience 제21권 제1호
- 발행연도
- 2023.2
- 수록면
- 135 - 146 (12page)
- DOI
- 10.9758/cpn.2023.21.1.135
이용수
초록· 키워드
오류제보하기
Objective: Anxious depression is associated with greater chronicity, higher severity of symptoms, more severe functional impairment, and poor response to drug treatment. However, evidence for first-choice antidepressants in patients with anxious depression is limited. This study aimed to compare the efficacy and safety of escitalopram, desvenlafaxine, and vortioxetine in the acute treatment of anxious depression.
Methods: Patients (n = 124) with major depressive disorder and high levels of anxiety were randomly assigned to an escitalopram treatment group (n = 42), desvenlafaxine treatment group (n = 40), or vortioxetine treatment group (n = 42) in a 6-week randomized rater-blinded head-to-head comparative trial. Changes in overall depressive and anxiety symptoms were assessed using the 17-item Hamilton Depression Rating Scale (HAMD) and Hamilton Anxiety Rating Scale (HAMA), respectively.
Results: Patients demonstrated similar baseline-to-endpoint improvement in scores and similar response and remission rates for HAMD and HAMA. Analysis of the individual HAMD items revealed that desvenlafaxine significantly reduced anxiety somatic scores (p = 0.013) and hypochondriasis scores (p = 0.014) compared to escitalopram. With respect to the individual HAMA items, desvenlafaxine treatment showed significantly lower scores for respiratory symptoms (p = 0.013) than escitalopram treatment and cardiovascular symptoms (p = 0.005) than vortioxetine treatment. The treatments were well tolerated, with no significant differences.
Conclusion: Our results indicated no significant differences in the efficacy and tolerability of escitalopram, desvenlafax ine, and vortioxetine in this subtype of patients with anxious depression during the acute phase of treatment.
목차
등록된 정보가 없습니다.
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study
PSYCHIATRY INVESTIGATION
2022 .04
-
Effects of Escitalopram on Anxiety in Patients with Acute Coronary Syndrome: A Randomized Controlled Trial
Clinical Psychopharmacology and Neuroscience
2017 .01
-
Vortioxetine Treatment for Depression in Alzheimer’s Disease: A Randomized, Double-blind, Placebo-controlled Study
Clinical Psychopharmacology and Neuroscience
2022 .05
-
Erratum : Acute Efficacy and Safety of Escitalopram Versus Desvenlafaxine and Vortioxetine in the Treatment of Depression With Cognitive Complaint: A Rater-Blinded Randomized Comparative Study
PSYCHIATRY INVESTIGATION
2022 .06
-
The Clinical Characteristics and Manifestation of Anxious Depression Among Patients With Major Depressive Disorders-Results From a Taiwan Multicenter Study
PSYCHIATRY INVESTIGATION
2024 .06
-
Paroxetine versus Venlafaxine and Escitalopram in Korean Patients with Major Depressive Disorder: A Randomized, Rater-blinded, Six-week Study
Clinical Psychopharmacology and Neuroscience
2017 .01
-
Early Improvement in One Week Predicts the Treatment Response to Escitalopram in Patients with Social Anxiety Disorder: A Preliminary Study
Clinical Psychopharmacology and Neuroscience
2016 .01
-
Associations between Serotonergic Genes and Escitalopram Treatment Responses in Patients with Depressive Disorder and Acute Coronary Syndrome: The EsDEPACS Study
PSYCHIATRY INVESTIGATION
2016 .01
-
Association between Obsessive-Compulsive Symptoms and Long-Term Cardiac Outcomes in Patients with Acute Coronary Syndrome: Effects of Depression Comorbidity and Treatment
PSYCHIATRY INVESTIGATION
2019 .01
-
Reduced Venous Blood Basophil Count and Anxious Depression in Patients with Major Depressive Disorder
PSYCHIATRY INVESTIGATION
2016 .01
-
Comparing the Effects of Bupropion and Escitalopram on Excessive Internet Game Play in Patients with Major Depressive Disorder
Clinical Psychopharmacology and Neuroscience
2017 .01
-
Escitalopram, a selective serotonin reuptake inhibitor, inhibits voltage-dependent K+ channels in coronary arterial smooth muscle cells
The Korean Journal of Physiology & Pharmacology
2017 .07
-
Long-Term Use of Escitalopram and a High Level of Carcinoembryonic Antigen
Korean Journal of Family Medicine
2016 .01
-
보티옥세틴이 C57BL/6형 생쥐의 알코올 섭취량에 미치는 영향
생물치료정신의학
2023 .10
-
Escitalopram-Induced Amenorrhea and False Positive Urine Pregnancy Test
Korean Journal of Family Medicine
2017 .01
-
Factor Structure of the Hamilton Depression Rating Scale for Patients with Major Depression with the Anxious Distress Specifier in DSM-5
우울조울병
2019 .01
-
Differences in Therapeutic Responses and Factors Affecting Post-Stroke Depression at a Later Stage According to Baseline Depression
대한뇌졸중학회지
2018 .01
-
한국형 우울장애 약물치료 알고리듬 2021 (II): 임상 아형
신경정신의학
2021 .08
-
The question of preoperative anxiety and depression in older patients and family protectors
Anesthesia and Pain Medicine
2020 .01
-
Network Analysis of the Symptoms of Depressive Disorders Over the Course of Therapy: Changes in Centrality Measures
PSYCHIATRY INVESTIGATION
2021 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0